GDF15 and its receptors as pathways mediating smoking related weight change
CHEN Z. et al, (2025), eBioMedicine
A Mendelian randomisation study of the effect of body mass index on 52 causes of death among 125 000 Mexican adults with admixed ancestry
Gnatiuc Friedrichs L. et al, (2025), International Journal of Epidemiology
Clinically-validated graphical approaches identify hepatosplenic multimorbidity in individuals at risk of schistosomiasis
Zhi Y-C. et al, (2025), Royal Society Open Science
Effect of supplementation with vitamin D on biochemical markers of iron status and erythropoiesis in older people: BEST-D trial.
Lamikanra AA. et al, (2025), Br J Nutr, 1 - 18
Sotrovimab versus usual care in patients admitted to hospital with COVID-19: a randomised, controlled, open-label, platform trial (RECOVERY)
HORBY P. et al, (2025), The Lancet Infectious Diseases
Association of greenness with incidence of cardiovascular disease in China: Evidence from the China Kadoorie Biobank prospective cohort study with 0.5 million adults
Meng X. et al, (2025), Eco-Environment and Health, 4
Corrigendum to Associations of reallocating sedentary leisure-time to alternative discretionary movement behaviours with incident cardiometabolic diseases in 0.5 million Chinese adults. The Lancet Regional Health—Western Pacific, Volume 57, 101524 (The Lancet Regional Health - Western Pacific (2025) 57, (S2666606525000616), (10.1016/j.lanwpc.2025.101524))
Collings PJ. et al, (2025), The Lancet Regional Health - Western Pacific, 59
Lung development genes, adult lung function and cardiovascular comorbidities.
Portas L. et al, (2025), Thorax
Identification of recurrences in women diagnosed with early invasive breast cancer using routinely collected data in England.
Probert J. et al, (2025), BJC Rep, 3
Implementation of Delirium Screening at Scale in Older Patients With Emergency Hospital Admission.
Boucher EL. et al, (2025), JAMA Intern Med
Association of multimorbidity and disease clusters with neuroimaging and cognitive outcomes in UK Biobank.
Abid SUA. et al, (2025), J Prev Alzheimers Dis
Using a Markov Model and Real-World Evidence to Identify the Most Cost-Effective Cholesterol Treatment Escalation Threshold for the Secondary Prevention of Cardiovascular Disease.
Mariani A. et al, (2025), Appl Health Econ Health Policy
Correction: Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care.
Hin H. et al, (2025), Osteoporos Int
Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19: a randomised, controlled, open-label, platform trial (RECOVERY)
HORBY PW. et al, (2025), The Lancet Infectious Diseases
Cancer inequalities in the United Kingdom and the data used to measure them: a scoping review.
Underwood S. et al, (2025), Lancet Reg Health Eur, 52
Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression
Greene T. et al, (2025), Clinical Journal of the American Society of Nephrology, 20, 632 - 641
MORTALITY RISKS IN SUBTYPES OF WHITE-COAT HYPERTENSION: IMPLICATIONS FOR THE DIAGNOSIS OF WHITE-COAT HYPERTENSION
De la Sierra A. et al, (2025), Journal of Hypertension, 43, e11 - e12